https://pipelinereview.com/rheos-medicines-receives-fda-study-may-proceed-letter-to-initiate-phase-1-clinical-study-under-its-investigational-new-drug-application-for-rhx-317-for-treatment-of-autoimmune-and-inflammatory-disease/